Related Experiment Video
Updated: Jun 21, 2026

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Published on: June 4, 2017
Virotherapy against malignant glioma stem cells
Mahua Dey1, Ilya V Ulasov, Maciej S Lesniak
1The Brain Tumor Center, The University of Chicago, Chicago, IL, USA.
Glioblastoma stem cells drive poor outcomes. Virotherapy shows promise for targeting these self-renewing cells, offering a novel treatment strategy for this aggressive brain cancer.
Area of Science:
- Neuro-oncology
- Cancer stem cell biology
- Virology
Background:
- Glioblastoma multiforme is the most aggressive primary brain tumor with poor prognosis.
- Current treatments (surgery, chemotherapy, radiation) have limited efficacy.
- The cancer stem cell hypothesis offers new therapeutic targets.
Purpose of the Study:
- To review the existence and characteristics of glioma stem cells.
- To explore virotherapy as a potential treatment for glioblastoma.
- To assess the feasibility of targeting glioma stem cells with oncolytic viruses.
Main Methods:
- Literature review of glioma stem cell research.
- Analysis of studies on virotherapy in preclinical models.
- Evaluation of conditionally replicative viruses for cancer treatment.
Main Results:
- Evidence supports the existence of glioma stem cells with self-renewing properties.
- Glioma stem cells contribute to tumor recurrence and treatment resistance.
- Conditionally replicative viruses demonstrate selective replication in cancer cells, including glioma stem cells.
Conclusions:
- Glioma stem cells are a critical therapeutic target in glioblastoma.
- Virotherapy presents a promising strategy to specifically eliminate glioma stem cells.
- Targeting cancer stem cells with virotherapy may improve glioblastoma treatment outcomes.
More Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...